1. Home
  2. FULC vs CAN Comparison

FULC vs CAN Comparison

Compare FULC & CAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FULC
  • CAN
  • Stock Information
  • Founded
  • FULC 2015
  • CAN 2013
  • Country
  • FULC United States
  • CAN Singapore
  • Employees
  • FULC N/A
  • CAN N/A
  • Industry
  • FULC Biotechnology: Pharmaceutical Preparations
  • CAN Semiconductors
  • Sector
  • FULC Health Care
  • CAN Technology
  • Exchange
  • FULC Nasdaq
  • CAN Nasdaq
  • Market Cap
  • FULC 468.1M
  • CAN 511.2M
  • IPO Year
  • FULC 2019
  • CAN 2019
  • Fundamental
  • Price
  • FULC $11.74
  • CAN $0.97
  • Analyst Decision
  • FULC Buy
  • CAN Strong Buy
  • Analyst Count
  • FULC 7
  • CAN 7
  • Target Price
  • FULC $10.43
  • CAN $3.57
  • AVG Volume (30 Days)
  • FULC 922.1K
  • CAN 45.8M
  • Earning Date
  • FULC 10-29-2025
  • CAN 11-18-2025
  • Dividend Yield
  • FULC N/A
  • CAN N/A
  • EPS Growth
  • FULC N/A
  • CAN N/A
  • EPS
  • FULC N/A
  • CAN N/A
  • Revenue
  • FULC N/A
  • CAN $422,228,000.00
  • Revenue This Year
  • FULC N/A
  • CAN $78.34
  • Revenue Next Year
  • FULC N/A
  • CAN $50.58
  • P/E Ratio
  • FULC N/A
  • CAN N/A
  • Revenue Growth
  • FULC 2752.05
  • CAN 83.87
  • 52 Week Low
  • FULC $2.32
  • CAN $0.53
  • 52 Week High
  • FULC $12.14
  • CAN $3.27
  • Technical
  • Relative Strength Index (RSI)
  • FULC 72.74
  • CAN 42.57
  • Support Level
  • FULC $7.51
  • CAN $0.83
  • Resistance Level
  • FULC $9.05
  • CAN $1.28
  • Average True Range (ATR)
  • FULC 0.80
  • CAN 0.14
  • MACD
  • FULC 0.27
  • CAN -0.05
  • Stochastic Oscillator
  • FULC 89.63
  • CAN 21.15

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

About CAN Canaan Inc.

Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.

Share on Social Networks: